Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B

Open Access

Peer-reviewed

Research Article

Hua Zhang,

Affiliation Department of Medical Insurance, School of Public Health, Southeast University, Nanjing, Jiangsu, China
⨯
Mingdong Huo,

Affiliation Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu, China
⨯
Jianqian Chao,

Affiliation Department of Medical Insurance, School of Public Health, Southeast University, Nanjing, Jiangsu, China
⨯
Pei Liu

* E-mail: liupeiseu@163.com

Affiliations Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, Jiangsu, China, Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China
⨯

Reader Comments (0)

Monte Carlo method
Is the Subject Area "Monte Carlo method" applicable to this article?

Thanks for your feedback.
Hepatitis B
Is the Subject Area "Hepatitis B" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Markov models
Is the Subject Area "Markov models" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Hepatitis B virus
Is the Subject Area "Hepatitis B virus" applicable to this article?

Thanks for your feedback.
Life expectancy
Is the Subject Area "Life expectancy" applicable to this article?

Thanks for your feedback.